Monday, August 31, 2026

Fomento Economico Mexicano S.A.B. De C.V. Already 5% Down, Almost One Hour Before The NYSE Open

Fomento Economico Mexicano S.A.B. De C.V. Already 5% Down, Almost One Hour Before The NYSE Open

(VIANEWS) - The NYSE opens in less than one hour and Fomento Economico Mexicano S.A.B. de C.V.'s pre-market value is already 5.81% down.

Fomento Economico Mexicano S.A.B. de C.V.'s last close was $125.28, 12.65% under its 52-week high of $143.43.

The last session, NYSE ended with Fomento Economico Mexicano S.A.B. de C.V. (FMX) jumping 0.6% to $125.28. NYSE slid 0.73% to $17,886.27, following the last session's downward trend on what was a somewhat negative trend exchanging session.

About Fomento Economico Mexicano S.A.B. de C.V.

Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of collers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. Further, it operates small-box retail and food convenience chain stores in Switzerland, Germany, Austria, Luxembourg, and the Netherlands under the k kiosk, Brezelkönig, BackWerk, Ditsch, Press & Books, avec, Caffè Spettacolo, and ok.–) names, as well as pretzels under the Ditsch name. The company was founded in 1890 and is based in Monterrey, Mexico.

Earnings Per Share

As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $1.13.

PE Ratio

Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 110.87. Meaning, the purchaser of the share is investing $110.87 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.59%.

Yearly Top and Bottom Value

Fomento Economico Mexicano S.A.B. de C.V.'s stock is valued at $125.28 at 09:30 EST, way below its 52-week high of $143.43 and way higher than its 52-week low of $85.66.

Volume

Today's last reported volume for Fomento Economico Mexicano S.A.B. de C.V. is 372132 which is 41.07% below its average volume of 564080.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Fomento Economico Mexicano S.A.B. de C.V.'s EBITDA is 8.38.

More news about Fomento Economico Mexicano S.A.B. de C.V. (FMX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com